Hearing March 28 on Meth Elimination Act - The Missourian: Politics

default avatar
Welcome to the site! Login or Signup below.
|
||
Logout|My Dashboard

Hearing March 28 on Meth Elimination Act

Print
Font Size:
Default font size
Larger font size

Posted: Wednesday, March 28, 2012 8:04 am | Updated: 9:51 am, Wed Jun 6, 2012.

A bill that would require a prescription to buy certain cold and allergy medicines containing pseudoephedrine was scheduled for its first committee hearing Wednesday.

The Meth Elimination Act sponsored by state Rep. Dave Schatz, Sullivan, was to be heard by the Crime Prevention and Public Safety Committee.

Pseudoephedrine is the only ingredient that is vital to making meth.

A similar bill filed by Schatz last session was not passed by the Legislature.

Schatz recently filed the new bill after development of a new formulation that prevents the extraction of most of the pseudoephedrine from medicines.

Under Schatz’s new bill, any formula that blocks 95 percent or more of pseudoephedrine from being extracted, would not require a prescription.

The formula was developed by a Maryland Heights firm, Highland Pharmaceuticals, and recently passed all laboratory trials.

Opposition to the new bill is expected from pharmaceutical lobbyists and some medical groups.

Another bill making its way through the Legislature would reduce the amounts of cold and allergy medicines people could purchase and set tougher penalties for offenders.

/more_news/politics
(%remaining%) Remaining Thanks for visiting The Missourian. You're entitled to view 20 free articles every 30 days. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thanks for visiting The Missourian. You're entitled to view 20 free articles every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining We hope you will enjoy this free article on The Missourian. You're entitled to view 20 free articles every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining We hope you will enjoy this free article on The Missourian. You're entitled to view 20 free articles every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thank you for reading The Missourian. You have viewed (%remaining%) of your 20 free pages in 30 days. Please login or register at this time and enjoy the next (%remaining%) articles free of charge. After your 20 free articles, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thank you for reading The Missourian. Because you have already viewed this article, you may view it again as many times as you would like without subtracting from your remaining free article views.
(%remaining%) Remaining Thank you for registering on The Missourian. You're entitled to view 20 articles for free every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thank you for reading The Missourian. You're entitled to view 20 articles for free every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thank you for reading The Missourian. You're entitled to view 20 articles for free every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
(%remaining%) Remaining Thank you for reading The Missourian. You're entitled to view 20 articles for free every 30 days. This is your last free article this period. On your next article we'll ask you to purchase an affordable subscription.

Featured Ads